Universität zu Köln

Awasthi, Rakesh, Mueller, Karen Thudium, Yanik, Gregory A., Tam, Constantine S., Rives, Susana, McGuirk, Joseph P., Pulsipher, Michael A., Boyer, Michael W., Jaeger, Ulrich, Baruchel, Andre, Myers, Gary Douglas, Balke-Want, Hyatt, Schuster, Stephen J., Stefanski, Heather, Bishop, Michael R., Waldron, Edward R., Anak, Ozlem, Chakraborty, Abhijit, Bleickardt, Eric, Wong, Stephane, Pacaud, Lida Bubuteishvili, Waller, Edmund K. and Maude, Shannon L. (2018). Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Awasthi, Rakesh, Mueller, Karen Thudium, Yanik, Gregory A., Tam, Constantine Si Lun, Rives, Susana, McGuirk, Joseph, Boyer, Michael W., Jager, Ulrich, Baruchel, Andre, Myers, Gary Douglas, Borchmann, Peter, Jaglowski, Samantha Mary, Stefanski, Heather E., Bishop, Michael Russell, Waldron, Edward K., Hamilton, Jason, Cota, Mariana, Bubuteishvili-Pacaud, Lida and Waller, Edmund K. (2018). Considerations for tisagenlecleucel dosing rationale. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Awasthi, Rakesh, Pacaud, Lida, Waldron, Edward, Tam, Constantine S., Jager, Ulrich, Borchmann, Peter, Jaglowski, Samantha ORCID: 0000-0002-4335-2554, Foley, Stephen Ronan, van Besien, Koen ORCID: 0000-0002-8164-6211, Wagner-Johnston, Nina D., Kersten, Marie Jose, Schuster, Stephen J., Salles, Gilles, Maziarz, Richard T., Anak, Ozlem, del Corral, Christopher, Chu, Jufen, Gershgorin, Irina, Pruteanu-Malinici, Iulian, Chakraborty, Abhijit, Mueller, Karen Thudium and Waller, Edmund K. (2020). Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL. Blood Adv., 4 (3). S. 560 - 573. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537

Bishop, Michael R., Maziarz, Richard T., Waller, Edmund K. ORCID: 0000-0003-0816-6729, Jaeger, Ulrich, Westin, Jason R., McGuirk, Joseph P., Fleury, Isabelle, Holte, Harald ORCID: 0000-0001-9799-9428, Borchmann, Peter, del Corral, Christopher, Tiwari, Ranjan, Anak, Oezlem, Awasthi, Rakesh, Pacaud, Lida, Romanov, Vadim V. and Schuster, Stephen J. (2019). Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Adv., 3 (14). S. 2230 - 2237. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537

Jaeger, Ulrich, Tam, Constantine S., Borchmann, Peter, McGuirk, Joseph P., Johansen, Marianne, Waller, Edmund K., Jaglowski, Samantha ORCID: 0000-0002-4335-2554, Andreadis, Charalambos, Foley, Stephen R., Westin, Jason R., Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan ORCID: 0000-0002-8325-9215, Teshima, Takanori, Salles, Gilles, Schuster, Stephen J., He, Fiona, Maziarz, Richard T., Mayer, Sebastian, Makita, Shinichi, Kersten, Marie J., Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Goto, Hideki, Colicino, Silvia, Agarwal, Abhijit, Lobetti-Bodoni, Chiara and Bishop, Michael R. (2022). Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Blood Adv., 6 (16). S. 4816 - 4821. AMSTERDAM: ELSEVIER. ISSN 2473-9537

Jaeger, Ulrich, Worel, Nina, McGuirk, Joseph, Riedell, Peter A., Fleury, Isabelle, Borchmann, Peter, Du, Yan, Abdelhady, Ahmed M., Han, Xia, Martinez-Prieto, Marcela and Waller, Edmund K. (2021). Safety and efficacy of tisagenlecleucel (tisa-cel) plus pembrolizumab (pembro) in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): Updated analysis of the phase 1b PORTIA study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Maziarz, Richard T., Bishop, Michael R., Tam, Constantine S., Borchmann, Peter, Jaeger, Ulrich, McGuirk, Joseph, Waller, Edmund K., Jaglowski, Samantha, Andreadis, Charalambos, Foley, Stephen Ronan, Fleury, Isabelle, Mielke, Stephan, Westin, Jason R., Ho, Phoebe Joy, Bachanova, Veronika, Holte, Harald, Magenau, John M., Anak, Oezlem, Pacaud, Lida Bubuteishvili, Guenther, Siegbert, Zhang, Jie, Rasouliyan, Lawrence, Tai, Feng, Salles, Gilles A. and Schuster, Stephen J. (2018). Patient-Reported Quality of Life (QoL) Following Tisagenlecleucel Infusion in Adult Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL). Bone Marrow Transplant., 53. S. 177 - 179. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Maziarz, Richard T., Waller, Edmund K. ORCID: 0000-0003-0816-6729, Jaeger, Ulrich, Fleury, Isabelle, McGuirk, Joseph, Holte, Harald ORCID: 0000-0001-9799-9428, Jaglowski, Samantha ORCID: 0000-0002-4335-2554, Schuster, Stephen J., Bishop, Michael R., Westin, Jason R., Mielke, Stephan ORCID: 0000-0002-8325-9215, Teshima, Takanori, Bachanova, Veronika, Foley, Stephen R., Borchmann, Peter, Salles, Gilles A., Zhang, Jie, Tiwari, Ranjan, Pacaud, Lida B., Ma, Qiufei and Tam, Constantine S. (2020). Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Adv., 4 (4). S. 629 - 638. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537

Mueller, Karen Thudium, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael, Boyer, Michael W., August, Keith Jason, Myers, Gary Douglas, Awasthi, Rakesh, Waldron, Edward K., Bubuteishvili-Pacaud, Lida, Taran, Tanya, Cota, Mariana, Tam, Constantine Si Lun, Jager, Ulrich, Foley, Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K. and Laetsch, Theodore Willis (2018). Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mueller, Karen Thudium, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael A., Boyer, Michael W., August, Keith J., Myers, G. Doug, Tam, Constantine S., Jaeger, Ulrich, Foley, Stephen Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K., Awasthi, Rakesh, Potthoff, Bernd, Warren, Andy, Waldron, Edward R., McBlane, Fraser, Chassot-Agostinho, Andrea and Laetsch, Theodore W. (2021). Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Blood Adv., 5 (23). S. 4980 - 4992. AMSTERDAM: ELSEVIER. ISSN 2473-9537

Schuster, Stephen, Bishop, Michael R., Tam, Constantine, Waller, Edmund K., Borchmann, Peter, McGuirk, Joseph, Jaeger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason, Fleury, Isabelle, Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Mielke, Stephan, Magenau, John M., Holte, Harald, Anak, Oezlem, Pacaud, Lida, Awasthi, Rakesh, Tai, Feng, Salles, Gilles and Maziarz, Richard T. (2017). Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)-An Interim Analysis. Clin. Lymphoma Myeloma Leuk., 17. S. S373 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Schuster, Stephen J., Bishop, Michael R., Tam, Constantine, Borchmann, Peter, Jaeger, Ulrich, Waller, Edmund K., Holte, Harald, McGuirk, Joseph P., Jaglowski, Samantha, Tobinai, Kensei, Andreadis, Charalambos, Fleury, Isabelle, Mielke, Stephan, Teshima, Takanori, Westin, Jason R., Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Magenau, John M., Wagner-Johnston, Nina D., Kato, Koji, Kersten, Marie Jose, Van Besien, Koen, Chu, Jufen, Jary, Aline, Anak, Ozlem, Salles, Gilles and Maziarz, Richard Thomas T. (2018). Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Schuster, Stephen J., Bishop, Michael R., Tam, Constantine S., Waller, Edmund K., Borchmann, Peter, McGuirk, Joseph P., Jaeger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason R., Fleury, Isabelle, Bachanova, Veronika, Foley, S. Ronan, Ho, P. Joy p, Mielke, Stephan ORCID: 0000-0002-8325-9215, Magenau, John M., Holte, Harald, Pantano, Serafino, Pacaud, Lida B., Awasthi, Rakesh, Chu, Jufen, Anak, Ozlem, Salles, Gilles and Maziarz, Richard T. (2019). Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. N. Engl. J. Med., 380 (1). S. 45 - 57. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Schuster, Stephen J., Tam, Constantine S., Borchmann, Peter, Worel, Nina, McGuirk, Joseph P., Holte, Harald, Waller, Edmund K., Jaglowski, Samantha, Bishop, Michael R., Damon, Lloyd E., Foley, Stephen Ronan, Westin, Jason R., Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan ORCID: 0000-0002-8325-9215, Teshima, Takanori, Janakiram, Murali, Hsu, Jing-Mei, Izutsu, Koji, Kersten, Marie Jose, Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Martinez-Prieto, Marcela, Han, Xia, Tiwari, Ranjan, Salles, Gilles and Maziarz, Richard T. (2021). Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol., 22 (10). S. 1403 - 1416. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488